\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ patient\\ has\\ nonspecific\\ enhancing\\ nodules\\ that\\ will\\ be\\ followed\\ for\\ interval\\ change\\.\ \(0\)\
\-\ well\\ circumscribed\\ non\\-enhancing\\ area\\ in\\ the\\ left\\ breast\\ that\\ is\\ hyperintense\\ on\\ t2wi\\,\\ hypointense\\ on\\ t1wi\\ and\\ fat\\ saturated\\ t2\\ sequences\\ compatible\\ with\\ injected\\ silicone\\.\\ \\ post\\ gadolinium\\ images\\ demonstrate\\ symmetric\\ enhancement\\ of\\ breast\\ parenchyma\\ with\\ nonspecific\\ nodules\\ of\\ enhancement\\ with\\ non\\-aggressive\\ time\\ intensity\\ curves\\ \\(not\\ shown\\)\\.\\ \\ architectural\\ distortion\\ in\\ the\\ upper\\ breast\\ with\\ blooming\\ artifact\\ on\\ gradient\\ imaging\\ compatible\\ with\\ post\\ surgical\\ change\\.\ \(0\)\
\-\ siliconomas\\:\\ \\ silicone\\ granulomas\\ from\\ silicone\\ breast\\ augmentation\ \(0\)\
\-\ injected\\ silicone\ \(1\)\
\-\ free\\ silicone\\ from\\ silicone\\ breast\\ implant\\ rupture\ \(0\)\
\-\ 65\\ year\\ old\\ asian\\ female\\ with\\ prior\\ left\\ breast\\ reduction\\ and\\ subsequent\\ augmentation\\.\ \(0\)\
\-\ silicone\\ demonstrates\\ characteristic\\ low\\ signal\\ intensity\\ on\\ t1wi\\,\\ high\\ t2\\ signal\\,\\ with\\ decreased\\ signal\\ intensity\\ on\\ t2\\ fat\\ suppressed\\ imaging\\.\\ \\ patient\\'s\\ mammogram\\ was\\ obscured\\ by\\ the\\ presence\\ of\\ hyperdense\\ foci\\ in\\ the\\ breast\\ parenchyma\\ and\\ an\\ mri\\ was\\ recommended\\ for\\ evaluation\\ for\\ breast\\ cancer\\ screening\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ silicone\\:\\ 0\\.5703650835843592\ \(0\)\
\-\ breast\\:\\ 0\\.4141471952391225\ \(0\)\
\-\ augmentation\\:\\ 0\\.1760399035837638\ \(0\)\
\-\ t1wi\\:\\ 0\\.15577091394682843\ \(0\)\
\-\ injected\\:\\ 0\\.15577091394682843\ \(0\)\
\-\ intensity\\:\\ 0\\.15186087926321512\ \(0\)\
\-\ compatible\\:\\ 0\\.1425898148699908\ \(0\)\
\-\ nonspecific\\:\\ 0\\.13400478585494305\ \(0\)\
\-\ t2\\:\\ 0\\.12304452882300461\ \(0\)\
\-\ signal\\:\\ 0\\.12123604814602298\ \(0\)\
\-\ parenchyma\\:\\ 0\\.11582270606584105\ \(0\)\
\-\ nodules\\:\\ 0\\.11328773510929238\ \(0\)\
\-\ change\\:\\ 0\\.10804239616711205\ \(0\)\
\-\ on\\:\\ 0\\.10765333084682016\ \(0\)\
\-\ siliconomas\\:\\ 0\\.10255627763021712\ \(0\)\
\-\ curves\\:\\ 0\\.1002777377069614\ \(0\)\
\-\ with\\:\\ 0\\.09771568874376568\ \(0\)\
\-\ blooming\\:\\ 0\\.09389376096806044\ \(0\)\
\-\ enhancing\\:\\ 0\\.08931729145997899\ \(0\)\
\-\ fat\\:\\ 0\\.0886929907718198\ \(0\)\
\-\ obscured\\:\\ 0\\.08523124430590379\ \(0\)\
\-\ architectural\\:\\ 0\\.08295270438264805\ \(0\)\
\-\ enhancement\\:\\ 0\\.08206604187337327\ \(0\)\
\-\ suppressed\\:\\ 0\\.08195238106264838\ \(0\)\
\-\ asian\\:\\ 0\\.08148072622633704\ \(0\)\
\-\ saturated\\:\\ 0\\.08102622632728372\ \(0\)\
\-\ granulomas\\:\\ 0\\.08016399689666993\ \(0\)\
\-\ implant\\:\\ 0\\.07935743512972525\ \(0\)\
\-\ post\\:\\ 0\\.0775818330395865\ \(0\)\
\-\ t2wi\\:\\ 0\\.07626013493213357\ \(0\)\
\-\ distortion\\:\\ 0\\.07537760107815805\ \(0\)\
\-\ imaging\\:\\ 0\\.07493013670001211\ \(0\)\
\-\ gradient\\:\\ 0\\.07482207096171004\ \(0\)\
\-\ artifact\\:\\ 0\\.068880525197863\ \(0\)\
\-\ mammogram\\:\\ 0\\.068063412674842\ \(0\)\
\-\ hyperdense\\:\\ 0\\.06562767105833474\ \(0\)\
\-\ for\\:\\ 0\\.06482194163604311\ \(0\)\
\-\ interval\\:\\ 0\\.06450775476991508\ \(0\)\
\-\ hypointense\\:\\ 0\\.0627352503644342\ \(0\)\
\-\ reduction\\:\\ 0\\.062229214846659366\ \(0\)\
\-\ that\\:\\ 0\\.061873977874795615\ \(0\)\
\-\ symmetric\\:\\ 0\\.061092306890319525\ \(0\)\
\-\ 65\\:\\ 0\\.06100207278112974\ \(0\)\
\-\ gadolinium\\:\\ 0\\.05940089601268535\ \(0\)\
\-\ foci\\:\\ 0\\.05826742754166517\ \(0\)\
\-\ screening\\:\\ 0\\.057911353032920526\ \(0\)\
\-\ rupture\\:\\ 0\\.057633622273736855\ \(0\)\
\-\ characteristic\\:\\ 0\\.057633622273736855\ \(0\)\
\-\ sequences\\:\\ 0\\.05703041496134264\ \(0\)\
\-\ the\\:\\ 0\\.05689938929487518\ \(0\)\
\-\ hyperintense\\:\\ 0\\.05670746753837219\ \(0\)\
\-\ recommended\\:\\ 0\\.05670746753837219\ \(0\)\
\-\ from\\:\\ 0\\.05662636959607119\ \(0\)\
\-\ free\\:\\ 0\\.05549317623986704\ \(0\)\
\-\ shown\\:\\ 0\\.05526386026786659\ \(0\)\
\-\ circumscribed\\:\\ 0\\.05520718275652775\ \(0\)\
\-\ subsequent\\:\\ 0\\.053969874110682076\ \(0\)\
\-\ in\\:\\ 0\\.05320357525811311\ \(0\)\
\-\ presence\\:\\ 0\\.05122220892704312\ \(0\)\
\-\ was\\:\\ 0\\.04969022426552334\ \(0\)\
\-\ left\\:\\ 0\\.048636837055063366\ \(0\)\
\-\ followed\\:\\ 0\\.048140961872095635\ \(0\)\
\-\ cancer\\:\\ 0\\.04748387745968545\ \(0\)\
\-\ patient\\:\\ 0\\.04637382015932135\ \(0\)\
\-\ area\\:\\ 0\\.04618239812560206\ \(0\)\
\-\ will\\:\\ 0\\.04588385826598261\ \(0\)\
\-\ and\\:\\ 0\\.044193334861974236\ \(0\)\
\-\ decreased\\:\\ 0\\.044158207533138094\ \(0\)\
\-\ evaluation\\:\\ 0\\.04347636372940519\ \(0\)\
\-\ time\\:\\ 0\\.042255110906165676\ \(0\)\
\-\ of\\:\\ 0\\.04185314507454773\ \(0\)\
\-\ low\\:\\ 0\\.04090632674692081\ \(0\)\
\-\ high\\:\\ 0\\.04051630624913268\ \(0\)\
\-\ prior\\:\\ 0\\.039886625509911934\ \(0\)\
\-\ upper\\:\\ 0\\.038096028636804814\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03706145835926486\ \(0\)\
\-\ mri\\:\\ 0\\.036593726728080735\ \(0\)\
\-\ demonstrates\\:\\ 0\\.035815092056176695\ \(0\)\
\-\ surgical\\:\\ 0\\.03464904419778569\ \(0\)\
\-\ well\\:\\ 0\\.034518748979373674\ \(0\)\
\-\ female\\:\\ 0\\.03440049341475723\ \(0\)\
\-\ images\\:\\ 0\\.03297616064528257\ \(0\)\
\-\ has\\:\\ 0\\.03256298682270587\ \(0\)\
\-\ by\\:\\ 0\\.030273675293930668\ \(0\)\
\-\ be\\:\\ 0\\.028919318290032033\ \(0\)\
\-\ not\\:\\ 0\\.02814341645304639\ \(0\)\
\-\ an\\:\\ 0\\.027260882599070863\ \(0\)\
\-\ year\\:\\ 0\\.021970034109956182\ \(0\)\
\-\ old\\:\\ 0\\.02109883786159803\ \(0\)\
\-\ is\\:\\ 0\\.01952312616187253\ \(0\)\
